Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many people considering weight loss medication face a timing question: can I take semaglutide while trying to get pregnant? Current data suggests that stopping semaglutide at least two months before attempting conception may reduce theoretical risks, though robust fertility studies remain limited. PlexusDx helps you navigate this decision with personalized guidance and flexible treatment options designed for major life transitions.

What the Research Shows About Semaglutide and Conception

Semaglutide is a glucagon-like peptide-1 receptor agonist originally developed to treat type 2 diabetes, with weight loss benefits discovered during clinical trials. Animal reproduction studies showed some effects on fetal development at very high doses, but human pregnancy data remains sparse because pregnant individuals were excluded from initial weight loss trials. The FDA currently classifies compounded semaglutide in Pregnancy Category C, meaning animal studies showed effects but no adequate human data exists—a classification that requires careful individual consideration rather than automatic avoidance.

Several medical societies, including the American College of Obstetricians and Gynecologists, note that GLP-1 medications should ideally be discontinued before conception planning begins. A reasonable clinical approach suggests stopping semaglutide at least two months before attempting pregnancy, allowing the medication to clear your system and giving your body time to stabilize. This timeline is based on semaglutide's half-life (approximately one week) and a precautionary principle, not definitive evidence of danger.

How Semaglutide May Affect Ovulation and Menstrual Cycles

Weight loss itself—the intended effect of semaglutide—can restore regular ovulation in people with polycystic ovary syndrome (PCOS) or weight-related menstrual irregularities. Rapid weight loss from any medication may temporarily shift hormone levels, including estrogen and progesterone, sometimes causing cycle changes during the first few months of treatment. These shifts typically normalize as your weight stabilizes, and many fertility specialists view the eventual metabolic improvement as beneficial for conception chances.

Some people experience nausea or reduced appetite on semaglutide, which could theoretically affect nutritional intake needed for reproductive health. Adequate protein, iron, folate, and vitamin B12 are especially important during fertility windows and early pregnancy, so working with a healthcare provider to maintain balanced nutrition while on any weight loss therapy is essential. PlexusDx can connect you with practitioners who understand both GLP-1 therapy and fertility-focused nutrition planning.

Planning Your GLP-1 Treatment Timeline Around Conception Goals

If you're planning to conceive within the next 6–12 months, discussing semaglutide timing with your primary care doctor and fertility specialist (if applicable) should happen early. A practical approach involves starting treatment now, reaching your target weight or metabolic goal, then pausing semaglutide two months before you plan to try conceiving. This sequence allows you to experience the benefits of weight loss—improved insulin sensitivity, lower inflammation, better ovulatory function—while respecting the precautionary window.

PlexusDx offers Compounded Semaglutide Injection starting at $149 per month, with no membership fees or insurance requirements, making it accessible to test whether GLP-1 therapy aligns with your fertility timeline. If you later decide to pause treatment, you can easily stop without long-term contracts. Many patients find that weight loss achieved during GLP-1 therapy persists even after discontinuation, especially when combined with sustainable eating and exercise habits.

Personalized Genetic Insights for Fertility and Metabolic Health

PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes your genetic predisposition to metabolic and weight-related traits that directly influence fertility. Key variants in genes like FTO (rs9939609), MC4R (rs17782313), GLP1R (rs6923761), and GIPR (rs1800437) reveal how your body responds to GLP-1 therapy and weight loss, information that can help your fertility team understand your individual risk-benefit profile. Understanding your genetic pathway helps both you and your doctor make informed decisions about medication timing relative to conception attempts.

PlexusDx maps 14 distinct metabolic pathways across 49 peptides, providing over 150 genetic insights into how your body handles weight regulation and hormone balance. This personalized data can clarify whether rapid weight loss will benefit your fertility prospects and whether specific GLP-1 approaches align with your genetic profile. Sharing these results with your fertility specialist gives them actionable context for your conception planning.

Alternative GLP-1 Options if You Need Maximum Flexibility

If you prefer shorter-acting options or want maximum control over treatment gaps during conception attempts, PlexusDx offers multiple semaglutide formulations. Oral Semaglutide starts at $249 per month and may clear your system slightly faster than injections, though individual metabolism varies. The Microdose GLP-1 Protocol at $129 per month flat provides a gentler entry point if you want to test tolerance before committing to standard-dose therapy.

Some patients benefit from the GLP-Squared Injection (combining semaglutide and tirzepatide) for enhanced metabolic effects before conception pauses, while others prefer the simplicity of stopping a single agent. PlexusDx's licensed 503A compounding pharmacies can adjust your formulation based on your fertility timeline, serving all 50 states with HSA/FSA eligibility and transparent monthly pricing that never changes with dose adjustments—your dose may go up, but your price won't.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I get pregnant while taking semaglutide?

Becoming pregnant while actively taking semaglutide is theoretically possible but not recommended due to limited human pregnancy safety data. Most fertility and weight loss specialists suggest discontinuing semaglutide at least two months before conception attempts, then resuming after pregnancy and breastfeeding if desired. PlexusDx supports flexible treatment pauses for major life events like family planning without penalties or membership fees.

How long does semaglutide stay in your system?

Semaglutide has a half-life of approximately seven days, meaning roughly half the dose leaves your body each week. After two to three weeks of stopping injections, semaglutide reaches very low levels, though some trace amounts may persist for up to one month. The two-month pre-conception window recommended by many specialists provides extra safety margin and allows metabolic and hormonal adjustments.

Will weight loss from semaglutide improve my fertility?

Yes—weight loss itself significantly improves fertility outcomes in people with obesity or PCOS by restoring regular ovulation, improving egg quality, and enhancing insulin sensitivity. Many patients experience better menstrual cycles and conception rates after achieving 5–15% weight loss, benefits that often persist even after stopping semaglutide. PlexusDx helps you leverage these improvements by timing your treatment to reach weight goals before conception attempts.

What if I'm already pregnant and took semaglutide?

If you discover pregnancy while on semaglutide, contact your obstetric care team immediately for individualized guidance. Most experts recommend stopping semaglutide once pregnancy is confirmed, though inadvertent exposure during the first few weeks is not considered an emergency. Your doctor can discuss your specific exposure timeline and risk factors; PlexusDx recommends working closely with obstetric providers for any pregnancy-related medication decisions.

Does PlexusDx's genetic test help with fertility planning?

PlexusDx Precision Peptide Genetic Test analyzes variants in FTO, MC4R, GLP1R, and GIPR genes that influence metabolic health and weight regulation—factors directly affecting fertility outcomes. Understanding your genetic predisposition helps your fertility specialist predict how weight loss will impact your reproductive hormones and ovulation. This $99 add-on test maps 150+ insights across 49 peptides, giving you and your care team precise data for conception planning.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves